Overcoming the obstacles in the pharma/Biotech industry: 2008 update

Drug News and Perspectives

Volumn 22, Issue 1, 2009, Pages 39-51

  Graul, Ann I ^a   Revel, Paula ^a   Rosa, Esmeralda ^a   Cruces, Elisabet ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALENDRONIC ACID; ALFIMEPRASE; AMIFOSTINE; BIOGRASTIM; CALCIPOTRIOL; CIPROFLOXACIN; DONEPEZIL; DORZOLAMIDE; DRONABINOL; EPLERENONE; FILGRASTIM RATIOPHARM; GALANTAMINE; GENERIC DRUG; IRINOTECAN; LAMOTRIGINE; LEVALBUTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NISOLDIPINE; PRAMIPEXOLE; PROSTACYCLIN; RATIOGRASTIM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN; RISPERIDONE; ROPINIROLE; SUMATRIPTAN SUCCINATE; TACROLIMUS; TEVAGRASTIM; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; VALCOTE; VALPROATE SEMISODIUM; ZALEPLON;

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; DEMENTIA; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG WITHDRAWAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE FINANCING; HEALTH INSURANCE; HUMAN; LICENSING; PATENT; PRESCRIPTION;

EID: 62649100260     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2009.22.1.1303817     Document Type: Article

References (5)

1. The bitterest pill. Nature 2006, 444(7119): 532.
2. Cuatrecasas, P. Drug discovery in jeopardy. J Clin Invest 2006, 116(11): 2837.
3. Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2008 (PhRMA, March 2008). Available at http://www.phrma.org/files/2008%20Profile.pdf. Accessed November 25, 2008.
4. The case for personalized medicine (Personalized Medicine Coalition, November 2006). Available at http://www.personalizedmedicinecoalition.org/communications/ pmc_pub_11-06.php. Accessed November 25, 2008.
5. Kesse;, M. and Frank, F. A better prescription for drug-development financing. Nat Biotech 2007, 25(8): 859.